Several outlets are reporting on the development of mRNA vaccines beyond covid-19, with some focusing on their potential use in cancer treatment and others discussing the pipeline of various companies. The development of these vaccines is ongoing, with some companies making progress and others abandoning their efforts, such as sanofi's attempt to develop an mRNA seasonal flu vaccine. The pipeline of mRNA vaccines includes treatments for various diseases, with some showing promising results in clinical settings.